Ravi Dhanelay
About Ravi Dhanelay
Data last updated:
Ravi Dhanelay has 5 years in corporate governance. Holds Director role. Currently with 2 companies, including Eibo Services Private Limited and Pneomon Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Eibo Services Private Limited at ₹5.2 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Eibo Services Private Limited U72900MP2020PTC052910 | Director | 19 Jan 2021 | 2020 | ₹5.2 Lakh (FY 2024) | Active |
| Pneomon Pharma Private Limited U21001MP2023PTC065979 | Director | 29 May 2023 | 2023 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravi Dhanelay
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravi Dhanelay
Ravi Dhanelay has 5 years in corporate governance. Holds Director role. Currently with 2 companies, including Eibo Services Private Limited and Pneomon Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Eibo Services Private Limited at ₹5.2 Lakh (FY 2024).
Ravi Dhanelay is associated with 2 companies as Director, including Eibo Services Private Limited (₹5.2 Lakh), Pneomon Pharma Private Limited.
Ravi Dhanelay has expertise in General Business.
Ravi Dhanelay has 5 years in corporate governance.
By reported revenue, the largest current company of Ravi Dhanelay is Eibo Services Private Limited, with revenue of ₹5.2 Lakh (FY 2024).
Ravi Dhanelay currently holds positions at 2 companies: Eibo Services Private Limited (₹5.2 Lakh), Pneomon Pharma Private Limited.